Darlene Dobkowski, Managing Editor for CURE® magazine, has been with the team since October 2020 and has covered health care in other specialties before joining MJH Life Sciences. She graduated from Emerson College with a Master’s degree in print and multimedia journalism. In her free time, she enjoys buying stuff she doesn’t need from flea markets, taking her dog everywhere and scoffing at decaf.
Foreign-Born Patients With HCC May Have Improved Survival Versus U.S.-Born Patients
May 25th 2023Patients born outside of the U.S. may have improved liver cancer survival rates compared with U.S.-born patients, although more research is needed to determine what may be driving this effect, research showed.
Imbruvica May Cause High Blood Pressure, Expert Says Patients ‘Shouldn’t Be Afraid’
May 4th 2023Findings from a study demonstrated that patients may develop hypertension, or high blood pressure, as a result of treatment with Imbruvica for CLL, although it may be quickly managed without drug-drug interactions.
FDA Accepts Application Seeking Approval of Keytruda-Chemo Combo for Stomach Cancer Subtypes
April 13th 2023If approved by the FDA, Keytruda plus chemotherapy could provide a frontline therapy for patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.
Mental Health Linked to Emotional and Physical Distress in Older Patients With Metastatic Cancer
April 12th 2023Some factors may increase the risk for anxiety and depression in older patients with metastatic cancer including distress related to physical symptoms, relationships, healthy lifestyle and communication with their health care team.